JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Myocardial Perfusion Scintigraphy Provides Incremental Prognostic Value in Patients on the Kidney Transplant Waiting List

  • 0Department of Internal Medicine D, University Hospital Münster, Münster, Germany.
Clinical Transplantation +

|

February 21, 2025

|

February 21, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Myocardial perfusion scintigraphy (MPS) offers better cardiovascular risk prediction than dobutamine stress echocardiography (DSE) for kidney transplant candidates. This helps refine risk assessment for patients with end-stage renal disease awaiting transplantation.

Area Of Science

  • Cardiology
  • Nephrology
  • Transplantation Medicine

Background

  • Cardiovascular risk assessment in end-stage renal disease (ESRD) patients awaiting kidney transplantation (KTx) remains challenging.
  • Current risk stratification scores may not fully capture individual patient risk.
  • Noninvasive cardiac imaging modalities are frequently employed to evaluate these patients.

Purpose Of The Study

  • To compare the prognostic value of myocardial perfusion scintigraphy (MPS) and dobutamine stress echocardiography (DSE) for cardiovascular risk assessment in ESRD patients.
  • To evaluate the incremental prognostic utility of these tests beyond traditional risk scores.

Main Methods

  • Prospective enrollment of 356 ESRD patients undergoing cardiovascular risk assessment before KTx.
  • Assessment included the Münster Cardiovascular Risk Stratification Score (MCRSS), MPS, and DSE.
  • Coronary angiography was performed in high-risk patients or those with abnormal stress test findings.

Main Results

  • Long-term follow-up revealed a cardiovascular event rate of 2.43 per 100 person-years and 71.9% overall patient survival.
  • Mild perfusion deficits on MPS demonstrated incremental prognostic value for event-free survival in lower-risk patients.
  • Wall motion abnormalities on DSE did not show the same incremental prognostic value.

Conclusions

  • MPS provides valuable prognostic information for cardiovascular risk stratification in ESRD patients.
  • A modified MCRSS approach incorporating MPS is proposed for improved risk assessment in KTx candidates.
  • This strategy aims to optimize pre-transplant cardiovascular evaluation.

Keywords: